Oregon has enacted a new law granting health centers and certain grantees more flexibility in how they report 340B claims [...] …
Year: 2025
Five major drugmakers recently announced new contract pharmacy restriction exemptions for 340B covered entities located in South Dakota and other [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Provider groups are sharply criticizing the newly enacted, GOP-backed budget reconciliation bill, warning that its more than $1 trillion in [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
California state senators have amended new provider reporting and auditing requirements onto a bill barring drugmakers from placing 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Whether it’s new manufacturer restrictions affecting script and data qualification, amended state laws or regulations, or updated audit guidelines, the 340B landscape is constantly evolving. So, it’s no surprise that managing an organization’s 340B program is not easy
…
The New York State Assembly recently honored longtime pharmacy leader and 340B advocate Mark Malahosky with a resolution commemorating his [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Hospital and health care provider advocates this week once again urged federal lawmakers to reject a controversial GOP-backed reconciliation plan [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The head of a key U.S. House subcommittee that oversees 340B drug pricing program policy issues is leaving the chairmanship [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two large drug companies this week filed federal lawsuits seeking to strike down Oklahoma’s new law prohibiting drugmaker 340B contract [...] …